So I took almost a week off from “bredemarketing,” but it’s not like anything happened.
Well, except for a new COVID-19 variant and the attending travel shutdowns and other changes.
And now people are wondering when Omicron will hit the United States. Frankly, it’s probably already here.
But as we become more familiar with things, and as our technology improves, our responses are quicker.
Take this Thermo Fisher Scientific press release.
Thermo Fisher Scientific Inc. (NYSE:TMO)…today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of SARS-CoV-2, are not impacted by the emerging B.1.1.529, or Omicron variant, enabling accurate test results.
https://thermofisher.mediaroom.com/2021-11-29-Thermo-Fisher-Scientific-Confirms-Detection-of-SARS-CoV-2-in-Samples-Containing-the-Omicron-Variant-with-its-TaqPath-COVID-19-Tests
That’s quick.
But test results are one thing; minimization of harm is another.
Moderna is already at work on a treatment to address the Omicron variant. Within the next few weeks, he said the company will know whether the new strain will require an altogether new vaccine, a specially formulated booster, or simply a higher dose of vaccines currently available.
From https://www.newsweek.com/moderna-estimates-weeks-before-omicron-vaccine-resistance-understood-variant-spreads-1653983
Considering how long it took to develop the first vaccines (which were already developed at a breakneck pace), that’s quick also.
Bredemarket 